Bibiliografía

1. Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, et al. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost. 2008 Dec;100(6):1084-8. [PubMed]

2. Ageno W, Squizzato A, Togna A, Magistrali F, Mangini M, Fugazzola C, Dentali F. Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study. J Thromb Haemost. 2012 Jan;10(1):158-60. [PubMed]

3. Ageno W, Riva N, Schulman S, Beyer-Westendorf J, Bang SM, Senzolo M, et al. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Intern Med. 2015 Sep;175(9):1474-80. [PubMed]

4. Di Nisio M, Valeriani E, Riva N, Schulman S, Beyer-Westendorf J, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost. 2020 Jul;18(7):1562-8. [PubMed]

5. Valeriani E, Di Nisio M, Riva N, Cohen O, García-Pagan JC, Magaz M, et al. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis. Blood. 2021 Mar 4;137(9):1233-40. [PubMed]

6. Candeloro M, Valeriani E, Monreal M, Ageno W, Riva N, López-Reyes R, et al. Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis. Blood Adv. 2022 Aug 9;6(15):4516-23. [PubMed]

7. Søgaard KK, Farkas DK, Pedersen L, Sørensen HT. Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival. Blood. 2015 Aug 20;126(8):957-63. [PubMed]

8. Cohen O, Caiano LM, Tufano A, Ageno W. Cancer-Associated Splanchnic Vein Thrombosis. Semin Thromb Hemost. 2021 Nov;47(8):931-41. [PubMed]

9. Arellano-Rodrigo E, Álvarez-Larrán A, Reverter JC, Villamor N, Colomer D, Cervantes F. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. Haematologica. 2006 Feb;91(2):169-75. [PubMed]

10. Valeriani E, Di Nisio M, Riva N, Caiano LM, Porreca E, Bang SM, et al.; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost. 2021 Apr;19(4):983-91. [PubMed]

11. Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, et al.; ESMO Guidelines Committee. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol. 2023 Jan 10:S0923-7534(22)04786-X. Epub ahead of print. [PubMed]

12. Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021 Feb 23;5(4):927-74. Erratum in: Blood Adv. 2021 Apr 13;5(7):1953. [PubMed]

13. Riva N, Ageno W, Schulman S, Beyer-Westendorf J, Duce R, Malato A, et al.; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry. Lancet Haematol. 2016 Jun;3(6):e267-75. [PubMed]

14. Tufano A, Ageno W, Di Micco P, Niglio A, Rosa V, Ballaz A, et al.; RIETE Investigators. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thromb Res. 2018 Apr;164:69-74. [PubMed]